FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891777242> ?p ?o ?g. }

• W2891777242 endingPage "1418" @default.
• W2891777242 startingPage "1406" @default.
• W2891777242 abstract "The most common primary central nervous system tumor in adults is the glioblastoma multiforme (GBM). The highly invasive nature of GBM cells is a significant factor resulting in the inevitable tumor recurrence and poor patient prognosis. Tumor cells utilize structures known as invadopodia to faciliate their invasive phenotype. In this study, utilizing an array of techniques, including gelatin matrix degradation assays, we show that GBM cell lines can form functional gelatin matrix degrading invadopodia and secrete matrix metalloproteinase 2 (MMP-2), a known invadopodia-associated matrix-degrading enzyme. Furthermore, these cellular activities were augmented in cells that survived radiotherapy and temozolomide treatment, indicating that surviving cells may possess a more invasive phenotype posttherapy. We performed a screen of FDA-approved agents not previously used for treating GBM patients with the aim of investigating their “anti-invadopodia” and cytotoxic effects in GBM cell lines and identified a number that reduced cell viability, as well as agents which also reduced invadopodia activity. Importantly, two of these, pacilitaxel and vinorelbine tartrate, reduced radiation/temozolomide-induced invadopodia activity. Our data demonstrate the value of testing previously approved drugs (repurposing) as potential adjuvant agents for the treatment of GBM patients to reduce invadopodia activity, inhibit GBM cell invasion, and potentially improve patient outcome." @default.
• W2891777242 created "2018-09-27" @default.
• W2891777242 creator A5003231470 @default.
• W2891777242 creator A5029827265 @default.
• W2891777242 creator A5032753431 @default.
• W2891777242 creator A5033768625 @default.
• W2891777242 creator A5034665595 @default.
• W2891777242 creator A5054088397 @default.
• W2891777242 creator A5060906848 @default.
• W2891777242 creator A5071427206 @default.
• W2891777242 date "2018-12-01" @default.
• W2891777242 modified "2023-09-27" @default.
• W2891777242 title "Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs" @default.
• W2891777242 cites W1507054304 @default.
• W2891777242 cites W1516737592 @default.
• W2891777242 cites W1767515115 @default.
• W2891777242 cites W1856628224 @default.
• W2891777242 cites W1874366132 @default.
• W2891777242 cites W1967124430 @default.
• W2891777242 cites W1972657333 @default.
• W2891777242 cites W1978526423 @default.
• W2891777242 cites W1985878553 @default.
• W2891777242 cites W1988787904 @default.
• W2891777242 cites W1997774562 @default.
• W2891777242 cites W1998293167 @default.
• W2891777242 cites W2002063867 @default.
• W2891777242 cites W2003736915 @default.
• W2891777242 cites W2015176250 @default.
• W2891777242 cites W2018702739 @default.
• W2891777242 cites W2023393975 @default.
• W2891777242 cites W2023506783 @default.
• W2891777242 cites W2024459776 @default.
• W2891777242 cites W2029113895 @default.
• W2891777242 cites W2036317449 @default.
• W2891777242 cites W2039322564 @default.
• W2891777242 cites W2048384404 @default.
• W2891777242 cites W2053380718 @default.
• W2891777242 cites W2073969056 @default.
• W2891777242 cites W2077597313 @default.
• W2891777242 cites W2079142824 @default.
• W2891777242 cites W2082668371 @default.
• W2891777242 cites W2091233038 @default.
• W2891777242 cites W2093313266 @default.
• W2891777242 cites W2096287682 @default.
• W2891777242 cites W2102662115 @default.
• W2891777242 cites W2104958914 @default.
• W2891777242 cites W2112943208 @default.
• W2891777242 cites W2119669323 @default.
• W2891777242 cites W2122656686 @default.
• W2891777242 cites W2123713581 @default.
• W2891777242 cites W2125743967 @default.
• W2891777242 cites W2127439083 @default.
• W2891777242 cites W2134807618 @default.
• W2891777242 cites W2136270276 @default.
• W2891777242 cites W2144273675 @default.
• W2891777242 cites W2146629016 @default.
• W2891777242 cites W2148977460 @default.
• W2891777242 cites W2154561072 @default.
• W2891777242 cites W2158008575 @default.
• W2891777242 cites W2162960688 @default.
• W2891777242 cites W2164675211 @default.
• W2891777242 cites W2166223410 @default.
• W2891777242 cites W2166566864 @default.
• W2891777242 cites W2168987104 @default.
• W2891777242 cites W2312666913 @default.
• W2891777242 cites W2326393033 @default.
• W2891777242 cites W2389429156 @default.
• W2891777242 cites W2517125345 @default.
• W2891777242 cites W2522764770 @default.
• W2891777242 cites W2542937421 @default.
• W2891777242 cites W2744422984 @default.
• W2891777242 cites W2759884156 @default.
• W2891777242 cites W2770359108 @default.
• W2891777242 cites W2781525129 @default.
• W2891777242 cites W284164312 @default.
• W2891777242 cites W4243546533 @default.
• W2891777242 cites W4245392732 @default.
• W2891777242 doi "https://doi.org/10.1016/j.tranon.2018.08.012" @default.
• W2891777242 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6140414" @default.
• W2891777242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30219696" @default.
• W2891777242 hasPublicationYear "2018" @default.
• W2891777242 type Work @default.
• W2891777242 sameAs 2891777242 @default.
• W2891777242 citedByCount "13" @default.
• W2891777242 countsByYear W28917772422019 @default.
• W2891777242 countsByYear W28917772422020 @default.
• W2891777242 countsByYear W28917772422021 @default.
• W2891777242 countsByYear W28917772422022 @default.
• W2891777242 countsByYear W28917772422023 @default.
• W2891777242 crossrefType "journal-article" @default.
• W2891777242 hasAuthorship W2891777242A5003231470 @default.
• W2891777242 hasAuthorship W2891777242A5029827265 @default.
• W2891777242 hasAuthorship W2891777242A5032753431 @default.
• W2891777242 hasAuthorship W2891777242A5033768625 @default.
• W2891777242 hasAuthorship W2891777242A5034665595 @default.
• W2891777242 hasAuthorship W2891777242A5054088397 @default.
• W2891777242 hasAuthorship W2891777242A5060906848 @default.
• W2891777242 hasAuthorship W2891777242A5071427206 @default.

• next